Morgan Stanley Harvard Bioscience Inc Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Morgan Stanley holds 29,556 shares of HBIO stock, worth $11,822. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,556

Previous 84,702 65.11%

Holding current value

$11,822

Previous $48,000 72.92%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$0.28 - $0.69 $15,440 - $38,050	-55,146 Reduced 65.11%	29,556 $13,000
Q1 2025 May 15, 2025	SELL	$0.57 - $2.19 $110,296 - $423,769	-193,502 Reduced 69.55%	84,702 $48,000
Q4 2024 Feb 14, 2025	BUY	$2.02 - $2.82 $238,067 - $332,351	117,855 Added 73.5%	278,204 $587,000
Q3 2024 May 14, 2025	BUY	$2.64 - $3.54 $249,094 - $334,013	94,354 Added 142.97%	160,349 $431,000
Q3 2024 Nov 14, 2024	BUY	$2.64 - $3.54 $249,094 - $334,013	94,354 Added 142.97%	160,349 $431,000
Q2 2024 May 14, 2025	SELL	$2.77 - $4.63 $587,818 - $982,527	-212,209 Reduced 76.28%	65,995 $188,000
Q2 2024 Oct 17, 2024	SELL	$2.77 - $4.63 $38,835 - $64,912	-14,020 Reduced 17.52%	65,995 $188,000
Q2 2024 Aug 14, 2024	SELL	$2.77 - $4.63 $38,835 - $64,912	-14,020 Reduced 17.52%	65,995 $188,000
Q1 2024 Oct 17, 2024	BUY	$4.02 - $5.39 $56,360 - $75,567	14,020 Added 21.24%	80,015 $339,000
Q1 2024 Aug 16, 2024	SELL	$4.02 - $5.39 $118,851 - $159,355	-29,565 Reduced 26.98%	80,015 $339,000
Q1 2024 May 15, 2024	SELL	$4.02 - $5.39 $118,851 - $159,355	-29,565 Reduced 26.98%	80,015 $339,000
Q4 2023 Aug 16, 2024	BUY	$4.0 - $5.49 $174,340 - $239,281	43,585 Added 66.04%	109,580 $586,000
Q4 2023 Feb 13, 2024	BUY	$4.0 - $5.49 $209,496 - $287,533	52,374 Added 91.55%	109,580 $586,000
Q3 2023 Nov 15, 2023	SELL	$4.0 - $5.82 $1.34 Million - $1.95 Million	-335,596 Reduced 85.44%	57,206 $245,000
Q2 2023 Aug 14, 2023	BUY	$4.19 - $6.16 $1.64 Million - $2.41 Million	391,056 Added 22397.25%	392,802 $2.16 Million
Q1 2023 May 15, 2023	SELL	$2.45 - $4.22 $4,270 - $7,355	-1,743 Reduced 49.96%	1,746 $7,000
Q4 2022 Feb 14, 2023	SELL	$2.12 - $2.86 $99,126 - $133,727	-46,758 Reduced 93.06%	3,489 $9,000
Q3 2022 Nov 14, 2022	SELL	$2.33 - $3.92 $62,875 - $105,781	-26,985 Reduced 34.94%	50,247 $128,000
Q2 2022 Oct 27, 2022	BUY	$3.28 - $6.42 $211,133 - $413,255	64,370 Added 500.47%	77,232 $277,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $211,133 - $413,255	64,370 Added 500.47%	77,232 $277,000
Q1 2022 Oct 27, 2022	SELL	$5.16 - $7.14 $332,149 - $459,601	-64,370 Reduced 83.35%	12,862 $80,000
Q1 2022 May 13, 2022	SELL	$5.16 - $7.14 $29,412 - $40,698	-5,700 Reduced 30.71%	12,862 $80,000
Q4 2021 Feb 14, 2022	BUY	$6.37 - $8.18 $56,157 - $72,114	8,816 Added 90.46%	18,562 $131,000
Q3 2021 Nov 15, 2021	BUY	$6.98 - $8.47 $68,027 - $82,548	9,746 New	9,746 $69,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

22.6M

Call Options Held

101K

Put Options Held

22K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $16.7M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account